photosensitizer

envie a um amigo share this

Exploring the potential of 7,4′-di(diethylamino)flavylium as a novel photosensitizer for topical photodynamic therapy of skin cancer

Authors and Affiliations:

Patrícia Correia1, Paula Araújo1, Joana Marto2, Helena Ribeiro2, Nuno Mateus1, Victor de Freitas1, Joana Oliveira1 & Iva Fernandes1

1REQUIMTE/LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre, s/n, 4169-007 Porto, Portugal.

Porphyrin conjugated with monoclonal antibody anti-CD104 is a potential photosensitizer for bladder cancer treatment

Photodynamic therapy (PDT) is a promising method, which has been studied and applied to improve the treatment of several tumour types. PDT combines molecular oxygen, light and a photosensitizer (PS) to generate cytotoxic reactions in cancer cells. The potential of PSs conjugated with biomolecules which will be recognized by antigens or receptors overexpressed in cancer cells prompted us to synthesize and to validate the photodynamic activity of a porphyrin conjugated with human and bovine serum albumins, and the monoclonal antibody anti-CD104.